Research programs that would help make the HIV response more effective and affordable have been slashed. This will make it more difficult for officials as they look to guide the response forward ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.

Toronto Public Health has sent letters to around 2,500 patients, notifying them of potential exposure to HIV, hepatitis B, and hepatitis C due to an infection control breach at a Toronto ...

United States funding cuts to HIV/AIDS programmes in many African countries could lead to hundreds of thousands of deaths on the continent, health experts and aid organisations have warned.